Opko Health, Inc.
OPK
$1.34
-$0.05-3.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -3.28% | 4.57% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.28% | 4.57% | |||
| Cost of Revenue | -23.94% | -0.31% | |||
| Gross Profit | 146.03% | 61.81% | |||
| SG&A Expenses | -9.72% | 0.86% | |||
| Depreciation & Amortization | 0.45% | -2.10% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -5.35% | -0.15% | |||
| Operating Income | 10.77% | 10.70% | |||
| Income Before Tax | 125.49% | -121.47% | |||
| Income Tax Expenses | 240.61% | -144.00% | |||
| Earnings from Continuing Operations | 114.57% | -119.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 114.57% | -119.55% | |||
| EBIT | 10.77% | 10.70% | |||
| EBITDA | 16.71% | 15.40% | |||
| EPS Basic | 114.76% | -87.09% | |||
| Normalized Basic EPS | 62.45% | -93.54% | |||
| EPS Diluted | 114.76% | -87.09% | |||
| Normalized Diluted EPS | 62.61% | -93.54% | |||
| Average Basic Shares Outstanding | -1.38% | 17.34% | |||
| Average Diluted Shares Outstanding | -1.03% | 17.34% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||